ClinicalTrials.gov
public full text
Public Domain
Stakeholders of Rare Diseases Informing Values In Neuroethics
The purpose of this research study is to learn more about the perspectives of key stakeholders-patients, families, healthcare providers, and researchers-on the ethical challenges of small-scale, personalized treatment trials for rare neurological diseases (RND).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Ethical Issues and Recommendations in Psychedelic Research and Practice: A Scoping Review.#3804
- Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.#185768
- Pilot Study of Open-label Placebo to Treat Major Depressive Disorder#889512
- Editorial: Innovative approaches in glioma therapy: exploring new therapeutic frontiers, volume II#438735
- How digital medicine redefines the landscape of care: Ethical and legal consequences in the case of psychiatry.#455283
Record · ID 981918
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive